Stanolone: Pharmacology, Clinical Applications and Analytical Methods
Stanolone is a synthetic androgen hormone with anabolic effects used in breast cancer treatment, caution needed for side effects, LC-MS/MS for accurate serum measurement.
Feb 21，2024 API
Nilotinib: Pharmacokinetics, Tolerability and Dosage
Nilotinib, used in imatinib-resistant chronic myeloid leukaemia treatment, exhibits dose-dependent serum concentrations and good tolerability. The recommended dosage is 400 mg twice daily.
Feb 21，2024 API
Gliclazide: Pharmacodynamic Properties, Pharmacokinetic Properties and Therapeutic Efficacy
Gliclazide effectively reduces blood glucose levels in non-insulin dependent diabetes mellitus patients by improving insulin secretion and sensitivity with potential benefits for diabetic retinopathy.
Feb 21，2024 API
A brief introduction to Bixlozone
Bixlozone is mainly used to inhibit broadleaf weed and grassy weed growth by inhibiting 1-deoxy-d-xylulose 5-phosphate synthase, resulting in the disruption of plastid isoprenoid biosynthesis.
Feb 20，2024 Chemical pesticides 
Lancotrione: mode of action, uses, and synthesis method
Lancotrione was announced by Ishihara Sangyo Kaisha as a new herbicide in 2016. It was released in 2019 and commercialized in the form of sodium salts.
Feb 20，2024 Chemical pesticides 
What is the Charge of a Chlorine Ion?
The chloride ion is an anion (negatively charged ion) with the charge Cl?.
Feb 20，2024 Inorganic chemistry
What is the charge of magnesium in Magnesium chloride?
Magnesium chloride is a salt that is a typical ionic halide, and they are highly soluble in water.
Feb 20，2024 Inorganic chemistry
Piracetam: Pharmacological Effects and Pharmacokinetics
Piracetam influences neurotransmitters, enhances neuroplasticity, and exhibits vascular effects, supporting its therapeutic potential in neurological and vascular conditions.
Feb 20，2024 API
Estriol: Physiology and Clinical Uses
Estriol shows promise in managing multiple sclerosis and menopause-related symptoms due to its immunomodulatory and neuroprotective properties.
Feb 20，2024 API
Trametinib: Potent MEK Inhibitor with Specific Pharmacokinetic and Pharmacodynamic Properties
Trametinib has specific pharmacokinetic properties, high plasma protein binding, and limited drug interactions. It effectively targets MEK1 and MEK2 in targeted cancer therapy.
Feb 20，2024 API